Cargando…
The potential of deferasirox as a novel therapeutic modality in gastric cancer
BACKGROUND: Iron is a crucial element for cell proliferation, growth, and metabolism. However, excess iron and altered iron metabolism are both associated with tumor initiation and tumor growth. Deferasirox is an oral iron chelator. Although some studies have indicated that deferasirox is a promisin...
Autores principales: | Choi, Jung Hye, Kim, Jung Soon, Won, Young Woong, Uhm, Jieun, Park, Byeong Bae, Lee, Young Yiul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4785730/ https://www.ncbi.nlm.nih.gov/pubmed/26965928 http://dx.doi.org/10.1186/s12957-016-0829-1 |
Ejemplares similares
-
Correlation of Vascular Endothelial Growth Factor-D Expression and VEGFR-3-Positive Vessel Density with Lymph Node Metastasis in Gastric Carcinoma
por: Choi, Jung-Hye, et al.
Publicado: (2008) -
Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma
por: Song, Moo-Kon, et al.
Publicado: (2019) -
Effects of oral iron chelator deferasirox on human malignant lymphoma cells
por: Choi, Jong Gwon, et al.
Publicado: (2012) -
Pharmacogenetic Study of Deferasirox, an Iron Chelating Agent
por: Lee, Ji Won, et al.
Publicado: (2013) -
Hypersensitivity reaction with deferasirox
por: Sharma, Atul, et al.
Publicado: (2015)